122 related articles for article (PubMed ID: 10714502)
21. Novel cytotoxic 7-iminomethyl and 7-aminomethyl derivatives of camptothecin.
Dallavalle S; Ferrari A; Merlini L; Penco S; Carenini N; De Cesare M; Perego P; Pratesi G; Zunino F
Bioorg Med Chem Lett; 2001 Feb; 11(3):291-4. PubMed ID: 11212094
[TBL] [Abstract][Full Text] [Related]
22. Transport mechanism-based drug molecular design: novel camptothecin analogues to circumvent ABCG2-associated drug resistance of human tumor cells.
Ishikawa T; Ikegami Y; Sano K; Nakagawa H; Sawada S
Curr Pharm Des; 2006; 12(3):313-25. PubMed ID: 16454746
[TBL] [Abstract][Full Text] [Related]
23. Review camptothecin: current perspectives.
Li QY; Zu YG; Shi RZ; Yao LP
Curr Med Chem; 2006; 13(17):2021-39. PubMed ID: 16842195
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and pharmacology of new camptothecin drugs.
Driver RW; Yang LX
Mini Rev Med Chem; 2005 May; 5(5):425-39. PubMed ID: 15892685
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antitumor activity of ring A- and F-modified hexacyclic camptothecin analogues.
Sugimori M; Ejima A; Ohsuki S; Uoto K; Mitsui I; Kawato Y; Hirota Y; Sato K; Terasawa H
J Med Chem; 1998 Jun; 41(13):2308-18. PubMed ID: 9632364
[TBL] [Abstract][Full Text] [Related]
26. [Homocamptothecins--novel promising anticancer drugs as inhibitors of topoisomerase I].
Yang S; Zhang WN
Yao Xue Xue Bao; 2004 May; 39(5):396-400. PubMed ID: 15338888
[No Abstract] [Full Text] [Related]
27. In vitro cytotoxicity of 5-aminosubstituted 20(S)-camptothecins. Part 1.
Subrahmanyam D; Sarma VM; Venkateswarlu A; Sastry TV; Kulakarni AP; Rao DS; Reddy KV
Bioorg Med Chem; 1999 Sep; 7(9):2013-20. PubMed ID: 10530950
[TBL] [Abstract][Full Text] [Related]
28. Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.
Hertzberg RP; Caranfa MJ; Holden KG; Jakas DR; Gallagher G; Mattern MR; Mong SM; Bartus JO; Johnson RK; Kingsbury WD
J Med Chem; 1989 Mar; 32(3):715-20. PubMed ID: 2537428
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of novel A-ring modified hexacyclic camptothecin analogues.
Kim DK; Ryu DH; Lee JY; Lee N; Kim YW; Kim JS; Chang K; Im GJ; Kim TK; Choi WS
J Med Chem; 2001 May; 44(10):1594-602. PubMed ID: 11334569
[TBL] [Abstract][Full Text] [Related]
30. Antitumor agents. V. Synthesis and antileukemic activity of E-ring-modified (RS)-camptothecin analogues.
Ejima A; Terasawa H; Sugimori M; Ohsuki S; Matsumoto K; Kawato Y; Yasuoka M; Tagawa H
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):683-8. PubMed ID: 1611680
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antitumor activity of 20(S)-camptothecin derivatives: carbamate-linked, water-soluble derivatives of 7-ethyl-10-hydroxycamptothecin.
Sawada S; Okajima S; Aiyama R; Nokata K; Furuta T; Yokokura T; Sugino E; Yamaguchi K; Miyasaka T
Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1446-50. PubMed ID: 1934165
[TBL] [Abstract][Full Text] [Related]
32. The cascade radical annulation approach to new analogues of camptothecins. Combinatorial synthesis of silatecans and homosilatecans.
Curran DP; Josien H; Bom D; Gabarda AE; Du W
Ann N Y Acad Sci; 2000; 922():112-21. PubMed ID: 11193887
[TBL] [Abstract][Full Text] [Related]
33. Bioreduction activated prodrugs of camptothecin: molecular design, synthesis, activation mechanism and hypoxia selective cytotoxicity.
Zhang Z; Tanabe K; Hatta H; Nishimoto S
Org Biomol Chem; 2005 May; 3(10):1905-10. PubMed ID: 15889173
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antitumor activity of novel 20s-camptothecin analogues.
Li Q; Lv H; Zu Y; Qu Z; Yao L; Su L; Liu C; Wang L
Bioorg Med Chem Lett; 2009 Jan; 19(2):513-5. PubMed ID: 19056266
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological activity of some bile acid-based camptothecin analogues.
Li X; Zhao T; Cheng D; Chu C; Tong S; Yan J; Li QY
Molecules; 2014 Mar; 19(3):3761-76. PubMed ID: 24662087
[TBL] [Abstract][Full Text] [Related]
36. Indolizino[1,2-b]quinolines derived from A-D rings of camptothecin: synthesis and DNA interaction.
Perzyna A; Houssin R; Goossens JF; Pommery N; Marty C; Facompré M; Colson P; Houssier C; Bailly C; Hénichart JP
J Enzyme Inhib Med Chem; 2003 Apr; 18(2):101-9. PubMed ID: 12943193
[TBL] [Abstract][Full Text] [Related]
37. The novel silatecan 7-tert-butyldimethylsilyl-10-hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activity.
Bom D; Curran DP; Kruszewski S; Zimmer SG; Thompson Strode J; Kohlhagen G; Du W; Chavan AJ; Fraley KA; Bingcang AL; Latus LJ; Pommier Y; Burke TG
J Med Chem; 2000 Oct; 43(21):3970-80. PubMed ID: 11052802
[TBL] [Abstract][Full Text] [Related]
38. [Current status of camptothecin derivatives as natural antitumor agents].
Pan XD; Wang CY
Yao Xue Xue Bao; 2003 Sep; 38(9):715-20. PubMed ID: 14730926
[No Abstract] [Full Text] [Related]
39. Antitumor agents. 7. Synthesis and antitumor activity of novel hexacyclic camptothecin analogues.
Sugimori M; Ejima A; Ohsuki S; Uoto K; Mitsui I; Matsumoto K; Kawato Y; Yasuoka M; Sato K; Tagawa H
J Med Chem; 1994 Sep; 37(19):3033-9. PubMed ID: 7932525
[TBL] [Abstract][Full Text] [Related]
40. Camptothecin analogues with enhanced antitumor activity at acidic pH.
Adams DJ; Dewhirst MW; Flowers JL; Gamcsik MP; Colvin OM; Manikumar G; Wani MC; Wall ME
Cancer Chemother Pharmacol; 2000; 46(4):263-71. PubMed ID: 11052623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
